
Oxford Global’s 4th Annual Drug Discovery USA Congress will take place on 9 – 10 October 2017 in San Diego, USA, bringing together over 250 key opinion leaders in drug discovery. This exciting conference showcases the latest technologies and approaches being utilised across Immuno-therapy, Autoimmune diseases, Neuroscience and Oncology. Further sessions consider the key updates in medicinal and computational chemistry. The two-day congress offers an interactive platform for high level discussions, ensuring valuable networking and interactive sessions.
4 Interactive Streams:
♦ Drug Discovery Innovation and Strategies, Enabling Technologies for Immuno-therapy, Autoimmune Diseases, Neuroscience & Oncology
♦ Successful Phenotypic Drug Discovery: High Content Screening
♦ Discovery Chemistry: Medicinal and Computational Chemistry
♦ Discovery Chemistry: Medicinal Chemistry and Novel Approaches to Drug Design
Free Webinar Recording:
Advance in Fragmented-based Drug Discovery
Hosted by Vincent Stoll, Associate Director of Structural Biology, AbbVie
Download for Free: http://bit.ly/2cuVKoT
For further information regarding prices and possible discounts, please contact Guillaume Alonso on g.alonso@oxfordglobal.co.uk or call +44 (0)1865 248 455.